Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has been given a consensus rating of “Buy” by the eight research firms that are covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have covered the stock in the last […]
Forsta AP Fonden lessened its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 70.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,500 shares of the biotechnology company’s stock after selling 5,900 shares during the period. Forsta AP […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 4th. The shares were sold at an average price of $227.97, for a total transaction of $1,367,820.00. Following the completion of the transaction, the executive vice president now […]
Krensavage Asset Management LLC lowered its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 201,222 shares of the biotechnology company’s stock after selling 1,493 shares during the period. […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned a consensus rating of “Buy” from the eight ratings firms that are covering the firm, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued a report on the […]